loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2248965 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AGALSIDASE BETA (1)

filter

01 SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC (1)

filter

01 POWDER FOR SOLUTION (1)

filter

01 5MG/VIAL (1)

filter

01 Canada (1)

URL Supplier Web Content
POWDER FOR SOLUTION
5MG/VIAL
FABRAZYME
Canada
2248965
1.1ML
Prescription
Sanofi Company Banner

Iran Expo

Not Confirmed

envelop Contact Supplier

Looking for CTD TGA MCC DOSSIER APPLICATION 2248965

Looking for CTD TGA MCC DOSSIER APPLICATION 2248965 1

19

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is AGALSIDASE BETA, with a corresponding application number 2248965 and regulatory information .

proudly manufactured in the

Sanofi's FABRAZYME POWDER FOR SOLUTION, medication with 5MG/VIAL of AGALSIDASE BETA.

Post Enquiry
POST ENQUIRY